Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY
Capital Research Global Investors reported a 7.10% stake in Alnylam Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 14, 2026
Capital Research Global Investors reported a 7.10% stake in Alnylam Pharmaceuticals, Inc., 9,471,181 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).
- Stake
- 7.10%
- Shares
- 9,471,181
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Capital Research Global Investors | 7.10% | 9,471,181 |
Source
Related
- Alnylam Pharmaceuticals, Inc.
- Capital Research Global Investors
- Alnylam Pharmaceuticals, Inc. shareholders
- Schedule 13G · Capital Research Global Investors · Feb 13, 2025
- Form 4 · Supran Bryan · Oct 6, 2026
- Form 4 · Greenstreet Yvonne · Sep 22, 2026
- Form 4 · Pyott David E I · Jun 3, 2026
- Form 4 · Sigal Charles Elliott · May 22, 2026
- Form 4 · Amy Schulman · May 22, 2026